10-K Filing

ENVERIC BIOSCIENCES, INC. CIK: 890821 FY 2011

Filing Information

Form Type	10-K
Accession Number	`0001477932-12-000619`
Period End Date	20111231
Filing Date	20120307
Fiscal Year	2011
Fiscal Period	FY
XBRL Instance	spzr-20111231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 42 Income Statement 14 Cash Flow Statement 26 Stockholders Equity 9

Balance Sheet 42 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.79K	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.13K	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$18.23K	USD	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Other Current Assets	`OtherAssetsCurrent`	-	USD	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Other Current Assets	`OtherAssetsCurrent`	$4.22K	USD	Point-in-time
Preferred stock, issued shares	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, issued shares	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$1.13K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$22.45K	USD	Point-in-time
Preferred stock, outstanding shares	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total Assets	`Assets`	$22.45K	USD	Point-in-time
Total Assets	`Assets`	$1.13K	USD	Point-in-time
Preferred stock, outstanding shares	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Accounts Payable and Accrued Liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$10.64K	USD	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Accounts Payable and Accrued Liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$17.89K	USD	Point-in-time
Common stock, issued shares	`CommonStockSharesIssued`	6.50M	shares	Point-in-time
Loans from Stockholders	`LoansPayableCurrent`	-	USD	Point-in-time
Common stock, issued shares	`CommonStockSharesIssued`	12.14M	shares	Point-in-time
Loans from Stockholders	`LoansPayableCurrent`	$40.00K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$17.89K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$50.64K	USD	Point-in-time
Common stock, outstanding shares	`CommonStockSharesOutstanding`	6.50M	shares	Point-in-time
Common stock, outstanding shares	`CommonStockSharesOutstanding`	12.14M	shares	Point-in-time
Common shares, $.01 par value, 300,000,000 shares authorized, 12,142,000 and 6,500,000 shares issued and outstanding	`CommonStockValue`	$65.00K	USD	Point-in-time
Common shares, $.01 par value, 300,000,000 shares authorized, 12,142,000 and 6,500,000 shares issued and outstanding	`CommonStockValue`	$121.42K	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$47.25M	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$47.22M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-47.33M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-47.37M	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquity`	$-10.07K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquity`	$-49.52K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquity`	$4.55K	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$22.45K	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$1.13K	USD	Point-in-time

Income Statement 14 line items

Line Item	Tag	Value	Unit	Period
General and Administrative	`GeneralAndAdministrativeExpense`	$35.88K	USD	Annual
General and Administrative	`GeneralAndAdministrativeExpense`	$31.39K	USD	Annual
Operating Loss	`OperatingIncomeLoss`	$-31.39K	USD	Annual
Operating Loss	`OperatingIncomeLoss`	$-35.88K	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-35.88K	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-31.39K	USD	Annual
Income Taxes	`IncomeTaxExpenseBenefit`	$1.99K	USD	Annual
Income Taxes	`IncomeTaxExpenseBenefit`	$3.57K	USD	Annual
Net Loss	`NetIncomeLoss`	$-33.38K	USD	Annual
Net Loss	`NetIncomeLoss`	$-39.44K	USD	Annual
Basic and Diluted Loss per Share	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	Annual
Basic and Diluted Loss per Share	`EarningsPerShareBasicAndDiluted`	-	USD	Annual
Weighted-Average Shares Outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	8.46M	shares	Annual
Weighted-Average Shares Outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	6.50M	shares	Annual

Cash Flow Statement 26 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLoss`	$-33.38K	USD	Annual
Net Loss	`NetIncomeLoss`	$-39.44K	USD	Annual
Other Current Assets	`IncreaseDecreaseInOtherCurrentAssets`	$-4.22K	USD	Annual
Accounts Payable and Accrued Liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$7.25K	USD	Annual
Accounts Payable and Accrued Liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.23K	USD	Annual
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-30.35K	USD	Annual
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-40.67K	USD	Annual
Issuance of Common Stock	`ProceedsFromIssuanceOfCommonStock`	$20.00K	USD	Annual
Issuance of Common Stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Loans From Stockholders	`LoansFromStockholders`	$40.00K	USD	Annual
Loans From Stockholders	`LoansFromStockholders`	$27.45K	USD	Annual
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$47.45K	USD	Annual
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$40.00K	USD	Annual
Increase in Cash and Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$17.11K	USD	Annual
Increase in Cash and Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-666.00	USD	Annual
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$1.79K	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$1.13K	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$18.23K	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$1.79K	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$1.13K	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$18.23K	USD	Point-in-time
Cash paid during the period for Interest	`InterestPaid`	-	USD	Annual
Cash paid during the period for Interest	`InterestPaid`	-	USD	Annual
Cash paid during the period for Income Taxes	`IncomeTaxesPaid`	$2.12K	USD	Annual
Cash paid during the period for Income Taxes	`IncomeTaxesPaid`	$1.45K	USD	Annual
Repayment of loans from shareholders through issuance of common stock	`ThroughIssuanceOfCommonStock`	$67.45K	USD	Annual

Stockholders Equity 9 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, Amount	`StockholdersEquity`	$-10.07K	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$-49.52K	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$4.55K	USD	Point-in-time
Issuance of Common Stock, Amount	`StockIssuedDuringPeriodValueNewIssues`	$87.45K	USD	Annual
Net Loss	`NetIncomeLoss`	$-33.38K	USD	Annual
Net Loss	`NetIncomeLoss`	$-39.44K	USD	Annual
Ending Balance, Amount	`StockholdersEquity`	$-10.07K	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$-49.52K	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$4.55K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.